Measures – My Blog

ID: 249 NQF: None eMeasure ID: None

2026 MIPS Measure #249: Barrett’s Esophagus

Percentage of esophageal biopsy reports that document the presence of Barrett's mucosa that also include a statement about dysplasia.

ID: 250 NQF: None eMeasure ID: None

2026 MIPS Measure #250: Radical Prostatectomy Pathology Reporting

Percentage of radical prostatectomy pathology reports that include the pT category, the pN category, the Gleason score and a statement about margin status.

ID: 395 NQF: None eMeasure ID: None ✹ High Priority: Yes

2026 MIPS Measure #395: Lung Cancer Reporting (Biopsy/Cytology Specimens)

Pathology reports based on lung biopsy and/or cytology specimens with a diagnosis of primary non-small cell lung cancer classified into specific histologic type following…

ID: 396 NQF: None eMeasure ID: None ✹ High Priority: Yes

2026 MIPS Measure #396: Lung Cancer Reporting (Resection Specimens)

Pathology reports based on lung resection specimens with a diagnosis of primary lung carcinoma that include the pT category, pN category and for non-small…

ID: 397 NQF: None eMeasure ID: None ✹ High Priority: Yes

2026 MIPS Measure #397: Melanoma Reporting

Pathology reports for primary malignant cutaneous melanoma that include the pT category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence…

ID: 440 NQF: None eMeasure ID: None ✹ High Priority: Yes

2026 MIPS Measure #440: Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician

Percentage of biopsies with a diagnosis of cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), or melanoma (including in situ disease) in…

ID: 491 NQF: 3661 eMeasure ID: None ✹ High Priority: Yes

2026 MIPS Measure #491: Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status

Percentage of surgical pathology reports for primary colorectal, endometrial, gastroesophageal or small bowel carcinoma, biopsy or resection, that contain impression or conclusion of or…